Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Triple Negative Breast Cancer
Interventions: DRUG: Carboplatin|DRUG: Nab-paclitaxel|DRUG: Pembrolizumab
Sponsor: Case Comprehensive Cancer Center